Cystic Fibrosis Transmembrane Conductance Regulator (ATP-Binding Cassette Sub-Family C, Member 7) (CFTR) (C-Term) Antikörper

Antigen: Cystic Fibrosis Transmembrane Conductance Regulator (ATP-Binding Cassette Sub-Family C, Member 7) (CFTR)

Synonyme: CF, MRP7, ABC35, ABCC7, CFTR/MRP, TNR-CFTR, dJ760C5.1, CFTR

Epitope: C-Term

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human

Applikation: Immunhistochemie (IHC), Western Blot (WB)

Produktnummer: ABIN350208

Produktbeschreibung

Weitere Bezeichnung: CFTR (c-terminal region)

Swiss-Prot: P13569

Immunogen: A synthetic peptide from the c-terminal region of human CFTR conjugated to an immunogenic carrier protein was used as the immunogen.

Format: Lyophilized

Beschreibung: FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Defects in CFTR are the cause of congenital bilateral absence of the vas deferens (CBAVD). CBAVD is an important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. Subcellular location: Membrane, Multi-pass membrane protein. Tissue specificity: Found on the surface of the epithelial cells that line the lungs and other organs. Also known as: Cystic fibrosistransmembrane conductance regulator, Channel conductance-controlling ATPase, cAMP-dependent chloride channel, ATP-binding cassette transporter sub-family C member 7.

Spezifität: Appears to be specific for CFTR.

Anwendungen

Applikationshinweise: IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.

Reinheit: whole serum

Lagerung: Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Riordan, Rommens, Kerem et al.: "Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA." in: Science (New York, N.Y.), Vol. 245, Issue 4922, pp. 1066-73, 1989 (PubMed).

Chang, Hou, Jensen et al.: "Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion." in: The Journal of biological chemistry, Vol. 269, Issue 28, pp. 18572-5, 1994 (PubMed).

Gouya, Pascaud, Munck et al.: "Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient." in: Human mutation, Vol. 10, Issue 1, pp. 86-7, 1997 (PubMed).

Cheng, Moyer, Milewski et al.: "A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression." in: The Journal of biological chemistry, Vol. 277, Issue 5, pp. 3520-9, 2002 (PubMed).